Researchers at the private biotech firm Living Carbon have developed genetically modified poplar trees that utilize a photorespiration bypass to grow significantly faster. These trees capture approximately 50% more biomass…
Researchers at the California-based startup Profluent have developed the first AI-generated gene editor capable of modifying the human genome. By training large language models on massive biological datasets, the team…
Researchers at Denali Therapeutics have successfully demonstrated a method to transport large therapeutic enzymes across the blood-brain barrier using an engineered antibody fragment. The platform, known as the Transport Vehicle,…
Researchers have identified a potent compound produced by deep-sea Pseudonocardia bacteria that effectively inhibits bone resorption. This marine-derived molecule, Reveromycin A, is being adapted by hospital research teams to treat…
Researchers at Prometheus Materials have developed a zero-carbon bio-cement using microalgae and biomineralization. This process mimics coral reef formation to create high-strength building blocks that sequester carbon dioxide rather than…
Regeneron Pharmaceuticals has demonstrated that its gene therapy, DB-OTO, can restore hearing in children born with profound deafness due to OTOF gene mutations. The therapy uses a dual-vector viral system…
Google DeepMind has introduced AlphaProteo, an AI system capable of designing novel proteins that bind to specific target molecules with high affinity. This breakthrough significantly accelerates the development of new…
Researchers have discovered that the protein Interleukin-11 (IL-11) acts as a major driver of aging and organ decline in mammals. By blocking this protein in animal models, scientists successfully extended…
Insilico Medicine has advanced the first generative AI-discovered and AI-designed drug candidate into Phase II clinical trials. The drug, INS018_055, targets idiopathic pulmonary fibrosis, a chronic condition that causes progressive…
